Package 42571-275-10

{"route": ["ORAL"], "spl_id": "3afc3c42-1157-b612-e063-6294a90ac179", "openfda": {"nui": ["N0000192795", "N0000175448"], "upc": ["0342571275600"], "unii": ["BH3B64OKL9"], "rxcui": ["897021"], "spl_set_id": ["302c8270-4711-4ca4-bee8-be0738fbe094"], "pharm_class_epc": ["Potassium Channel Blocker [EPC]"], "pharm_class_moa": ["Potassium Channel Antagonists [MoA]"], "manufacturer_name": ["Micro Labs Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (42571-275-05)", "package_ndc": "42571-275-05", "marketing_start_date": "20190321"}, {"sample": false, "description": "1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (42571-275-10)", "package_ndc": "42571-275-10", "marketing_start_date": "20190321"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (42571-275-60)", "package_ndc": "42571-275-60", "marketing_start_date": "20190321"}], "brand_name": "DALFAMPRIDINE", "product_id": "42571-275_3afc3c42-1157-b612-e063-6294a90ac179", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Potassium Channel Antagonists [MoA]", "Potassium Channel Blocker [EPC]"], "product_ndc": "42571-275", "generic_name": "DALFAMPRIDINE", "labeler_name": "Micro Labs Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DALFAMPRIDINE", "active_ingredients": [{"name": "DALFAMPRIDINE", "strength": "10 mg/1"}], "application_number": "ANDA210158", "marketing_category": "ANDA", "marketing_start_date": "20190321", "listing_expiration_date": "20261231"}